EC Open Call FETOPEN-01-2016-2017: FET-Open Research and Innovation Actions

European CommissionThe successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas. Here agile, risk-friendly and highly interdisciplinary research approaches are needed with collaborations that are open to all sciences and disciplines and that dissolve the traditional boundaries between them. The renewal of ideas is complemented by the renewal of actors taking these new ideas forward. Therefore, this topic encourages the driving role of new high-potential actors in research and innovation, such as excellent young, both female and male, researchers and high-tech SMEs that may become the scientific and industrial leaders of the future.

This topic supports the early stages of research to establish a new technological possibility. Proposals are sought for collaborative research with all of the following characteristics ('FET gatekeepers'):

  • Long-term vision: the research proposed must address a new and radical long-term vision of a science- and technology-enabled future that is far beyond the state of the art and not currently foreseen by technology roadmaps.
  • Breakthrough scientific and technological target: research must target a scientifically ambitious and technologically concrete breakthrough, argued to be a crucial step towards achieving the long-term vision. The plausibility of the proposed breakthrough(s) to be attained within the life-time of the project must be argued in the proposal.
  • Novelty: the research proposed for achieving the breakthrough must be based on cutting-edge knowledge, new ideas and concepts, rather than in the mere application or incremental refinement of existing ones.
  • Foundational: the breakthroughs that are envisaged must be foundational in the sense that, if achieved, they would establish an essential basis for a new kind of technology and its future uses, not currently anticipated.
  • High-risk: the inherently high risk of the research proposed will be reflected in a flexible but effective methodology for exploring alternative directions and options, supported by open and agile research and innovation practices.
  • Interdisciplinary: the proposed collaborations are expected to go beyond 'waterfall' configurations in multi-disciplinary science- and technology research. Instead they should seek new solutions through genuine exchanges, mutual learning, cross-fertilisation and synergistic advances among distant disciplines in order to open unexplored areas of investigation and new directions for joint research.

The Commission considers that proposals requesting a contribution from the EU of up to EUR 3 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected Impact:

  • Initiating or consolidating a baseline of feasibility for a radically new line of technology and its future uses by establishing the essential proofs-of-principle and their foundational scientific underpinnings.
  • Strengthening European leadership in the early exploration of visionary, new and emerging technologies, beyond academic excellence and with global recognition. This impact can be reinforced by involving also new high-potential actors such as young, both female and male, researchers and high-tech SMEs that may become the European scientific and technological leaders and innovators of the future.
  • Impact is also sought in terms of the take up of new research and innovation practices for making leading-edge science and technology research more open, collaborative, creative and closer to society.

Deadline Model: multiple cut-off

Cut-off dates:
11 May 2016 17:00:00
17 January 2017 17:00:00
27 September 2017 17:00:00

Type of action: RIA Research and Innovation action.

For topic conditions, documents and submission service, please visit:
http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/fetopen-01-2016-2017.html

PS: Find your partners or consortia preparing a project proposal
If you are working on Horizon 2020 research project proposals and you would be interested in a SME partner from Germany, please contact us, we are happy to share our experience, expertise and knowledge. If you need help to identify a potential partner with particular competences, facilities or experience, please join and explore our project, (HEALTH IT) SPACE, at www.healthitspace.eu.

Most Popular Now

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...